$ACHV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHIEVE LIFE SCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACHIEVE LIFE SCIENCES, INC.. Get notifications about new insider transactions in ACHIEVE LIFE SCIENCES, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | ACHV | ACHIEVE LIFE SCIEN ... | MOYES JAY M | Director | Option Exercise | A | 9.90 | 3,750 | 37,125 | 3,750 | |
May 13 2021 | ACHV | ACHIEVE LIFE SCIEN ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 9.90 | 3,750 | 37,125 | 3,750 | |
May 13 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Joseph Donald | Director | Option Exercise | A | 9.90 | 3,750 | 37,125 | 3,750 | |
Mar 17 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Martell Bridget A | Director | Option Exercise | A | 12.10 | 5,650 | 68,365 | 5,650 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Wann Jerry | Principal Accountin ... | Option Exercise | A | 13.09 | 15,000 | 196,350 | 15,000 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Wann Jerry | Principal Accountin ... | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Executive Chairman | Option Exercise | A | 13.09 | 50,000 | 654,500 | 50,000 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Executive Chairman | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | President & CMO | Option Exercise | A | 13.09 | 30,000 | 392,700 | 30,000 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | President & CMO | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Clarke Anthony | CSO | Option Exercise | A | 13.09 | 8,000 | 104,720 | 8,000 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Clarke Anthony | CSO | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CEO | Option Exercise | A | 13.09 | 60,000 | 785,400 | 60,000 | |
Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CEO | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Nov 18 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Executive Chairman | Option Exercise | A | 10.36 | 15,000 | 155,400 | 15,000 | |
Nov 18 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Executive Chairman | Option Exercise | A | 10.36 | 15,000 | 155,400 | 15,000 | |
Nov 18 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | President & CMO | Option Exercise | A | 10.36 | 12,000 | 124,320 | 12,000 | |
Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 69 | 0 | 68 | |
Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Payment of Exercise | F | 8.95 | 33 | 295 | 141 | 174 to 141 (-18.97 %) |
Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Buy | M | 0.00 | 69 | 0 | 174 | 105 to 174 (+65.71 %) |
Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 69 | 0 | 68 | |
Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 8.95 | 33 | 295 | 176 | 209 to 176 (-15.79 %) |
Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 69 | 0 | 209 | 140 to 209 (+49.29 %) |
May 14 2020 | ACHV | ACHIEVE LIFE SCIEN ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 0.43 | 22,000 | 9,460 | 22,000 | |
May 14 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | A | 0.43 | 22,000 | 9,460 | 22,000 | |
May 14 2020 | ACHV | ACHIEVE LIFE SCIEN ... | MOYES JAY M | Director | Option Exercise | A | 0.43 | 22,000 | 9,460 | 22,000 | |
May 14 2020 | ACHV | ACHIEVE LIFE SCIEN ... | PARKER H STEWART | Director | Option Exercise | A | 0.43 | 22,000 | 9,460 | 22,000 | |
Jan 30 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 0.56 | 200,000 | 112,000 | 200,000 | |
Jan 30 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Clarke Anthony | President & CSO | Option Exercise | A | 0.56 | 200,000 | 112,000 | 200,000 | |
Jan 30 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.56 | 200,000 | 112,000 | 200,000 | |
Jan 30 2020 | ACHV | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Chairman & CEO | Option Exercise | A | 0.56 | 450,000 | 252,000 | 450,000 | |
Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,370 | 0 | 2,740 | |
Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 1.88 | 408 | 767 | 2,801 | 3.2 K to 2.8 K (-12.71 %) |
Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 1,370 | 0 | 3,209 | 1.8 K to 3.2 K (+74.50 %) |
Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 1,370 | 0 | 2,740 | |
Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Payment of Exercise | F | 1.88 | 408 | 767 | 2,101 | 2.5 K to 2.1 K (-16.26 %) |
Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Buy | M | 0.00 | 1,370 | 0 | 2,509 | 1.1 K to 2.5 K (+120.28 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 2.85 | 44,982 | 128,199 | 796,594 | 841.6 K to 796.6 K (-5.34 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.01 | 2,200 | 6,622 | 841,576 | 843.8 K to 841.6 K (-0.26 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 2.57 | 50,000 | 128,500 | 843,776 | 893.8 K to 843.8 K (-5.59 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 2.53 | 3,000 | 7,590 | 893,776 | 896.8 K to 893.8 K (-0.33 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 2.66 | 64,213 | 170,807 | 896,776 | 961 K to 896.8 K (-6.68 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 2.91 | 8,082 | 23,519 | 960,989 | 969.1 K to 961 K (-0.83 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.00 | 11,705 | 35,115 | 969,071 | 980.8 K to 969.1 K (-1.19 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.01 | 23,362 | 70,320 | 980,776 | 1 M to 980.8 K (-2.33 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.02 | 2,200 | 6,644 | 1,004,138 | 1 M to 1 M (-0.22 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.17 | 2,918 | 9,250 | 1,006,338 | 1 M to 1 M (-0.29 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.38 | 5,944 | 20,091 | 1,009,256 | 1 M to 1 M (-0.59 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.61 | 800 | 2,888 | 1,015,200 | 1 M to 1 M (-0.08 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.64 | 10,000 | 36,400 | 1,016,000 | 1 M to 1 M (-0.97 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 3.80 | 12,813 | 48,689 | 1,026,000 | 1 M to 1 M (+1.26 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 3.30 | 31,897 | 105,260 | 1,013,187 | 1 M to 1 M (-3.05 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 4.29 | 21,118 | 90,596 | 1,045,084 | 1.1 M to 1 M (-1.98 %) |
Jun 13 2019 | ACHV | ACHIEVE LIFE SCIEN ... | ARMISTICE CAPITAL, LLC | 10% Owner | Sell | S | 4.39 | 29,724 | 130,488 | 1,066,202 | 1.1 M to 1.1 M (-2.71 %) |
May 28 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Chairman & CEO | Buy | P | 3.61 | 17,500 | 63,093 | 212,530 | 195 K to 212.5 K (+8.97 %) |
May 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | MOYES JAY M | Director | Option Exercise | A | 4.02 | 7,000 | 28,140 | 7,000 | |
May 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Joseph Donald | Director | Option Exercise | A | 4.02 | 7,000 | 28,140 | 7,000 | |
May 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | A | 4.02 | 7,000 | 28,140 | 7,000 | |
Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 1.42 | 30,000 | 42,600 | 30,000 | |
Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Clarke Anthony | President & CSO | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Clarke Anthony | President & CSO | Option Exercise | A | 1.42 | 30,000 | 42,600 | 30,000 | |
Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Chairman & CEO | Option Exercise | A | 1.42 | 25,000 | 35,500 | 25,000 | |
Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Chairman & CEO | Option Exercise | A | 1.42 | 75,000 | 106,500 | 75,000 | |
Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 1.42 | 30,000 | 42,600 | 30,000 | |
Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 42 | 0 | 0 | |
Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 1.16 | 13 | 15 | 1,839 | 1.9 K to 1.8 K (-0.70 %) |
Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 42 | 0 | 1,852 | 1.8 K to 1.9 K (+2.32 %) |
Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 28 | 0 | 0 | |
Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Payment of Exercise | F | 1.16 | 9 | 10 | 1,139 | 1.1 K to 1.1 K (-0.78 %) |
Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Buy | M | 0.00 | 28 | 0 | 1,148 | 1.1 K to 1.1 K (+2.50 %) |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Chairman & CEO | Option Exercise | A | 2.56 | 101,000 | 258,560 | 101,000 | |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | PARKER H STEWART | Director | Option Exercise | A | 2.56 | 12,000 | 30,720 | 12,000 | |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | MOYES JAY M | Director | Option Exercise | A | 2.56 | 12,000 | 30,720 | 12,000 | |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 2.56 | 12,000 | 30,720 | 12,000 | |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Joseph Donald | Director | Option Exercise | A | 2.56 | 12,000 | 30,720 | 12,000 | |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 2.56 | 37,000 | 94,720 | 37,000 | |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | A | 2.56 | 12,000 | 30,720 | 12,000 | |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Clarke Anthony | President & CSO | Option Exercise | A | 2.56 | 37,000 | 94,720 | 37,000 | |
Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 2.56 | 50,000 | 128,000 | 50,000 | |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,370 | 0 | 4,110 | |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 43 | 0 | 42 | |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 45 | 0 | 0 | |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 28 | 0 | 0 | |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 2.78 | 472 | 1,312 | 1,810 | 2.3 K to 1.8 K (-20.68 %) |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 1,486 | 0 | 2,282 | 796 to 2.3 K (+186.68 %) |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 28 | 0 | 28 | |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 45 | 0 | 0 | |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | M | 0.00 | 1,370 | 0 | 4,110 | |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Payment of Exercise | F | 2.78 | 458 | 1,273 | 1,120 | 1.6 K to 1.1 K (-29.02 %) |
Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Buy | M | 0.00 | 1,443 | 0 | 1,578 | 135 to 1.6 K (+1,068.89 %) |
Jul 30 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | Chairman & CEO | Option Exercise | A | 3.37 | 52,000 | 175,240 | 52,000 | |
Jul 30 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 3.37 | 20,000 | 67,400 | 20,000 | |
Jul 30 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Clarke Anthony | President & CSO | Option Exercise | A | 3.37 | 20,000 | 67,400 | 20,000 | |
Jul 30 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 3.37 | 25,000 | 84,250 | 25,000 | |
Jul 30 2018 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO & COO | Option Exercise | A | 3.37 | 25,000 | 84,250 | 25,000 | |
Sep 12 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Option Exercise | M | 0.00 | 454 | 0 | 455 | |
Sep 12 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Payment of Exercise | F | 3.09 | 149 | 460 | 1,358 | 1.5 K to 1.4 K (-9.89 %) |
Sep 12 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Buy | M | 0.00 | 454 | 0 | 1,507 | 1.1 K to 1.5 K (+43.11 %) |
Sep 12 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Payment of Exercise | F | 3.09 | 1,491 | 4,607 | 14,810 | 16.3 K to 14.8 K (-9.15 %) |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | PARKER H STEWART | Director | Option Exercise | A | 4.57 | 11,000 | 50,270 | 11,000 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | MATTINGLY MARTIN A | Director | Option Exercise | A | 4.57 | 11,000 | 50,270 | 11,000 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | MOYES JAY M | Director | Option Exercise | A | 4.57 | 16,400 | 74,948 | 16,400 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Joseph Donald | Director | Option Exercise | A | 4.57 | 16,400 | 74,948 | 16,400 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Clarke Anthony | Chief Scientific Of ... | Grant | A | 0.00 | 6,364,335 | 0 | 6,364,335 | 0 to 6.4 M |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Clarke Anthony | Chief Scientific Of ... | Grant | A | 0.00 | 4,242,890 | 0 | 4,242,890 | 0 to 4.2 M |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Clarke Anthony | Chief Scientific Of ... | Grant | A | 0.00 | 6,364,335 | 0 | 6,364,335 | 0 to 6.4 M |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | President & CEO | Grant | A | 0.00 | 848,578 | 0 | 848,578 | 0 to 848.6 K |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Stewart Richard Alistair | President & CEO | Grant | A | 0.00 | 22,487,319 | 0 | 22,487,319 | 0 to 22.5 M |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Option Exercise | A | 4.57 | 274,000 | 1,252,180 | 274,000 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Bencich John | CFO | Option Exercise | A | 0.00 | 54,800 | 0 | 54,800 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 4.57 | 274,000 | 1,252,180 | 274,000 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 54,800 | 0 | 54,800 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | A | 4.57 | 11,000 | 50,270 | 11,000 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 454 | 0 | 0 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 852 | 0 | 0 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 284 | 0 | 0 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 852 | 0 | 0 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 1,705 | 0 | 0 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Option Exercise | M | 0.00 | 568 | 0 | 0 | |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Buy | M | 0.00 | 1,590 | 0 | 9,685 | 8.1 K to 9.7 K (+19.64 %) |
Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | Cormack Scott Daniel | Director | Buy | M | 0.00 | 3,125 | 0 | 16,302 | 13.2 K to 16.3 K (+23.72 %) |
Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 9,375 | |
Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 5,000 | 0 | 89,055 | 84.1 K to 89.1 K (+5.95 %) |
Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Payment of Exercise | F | 0.36 | 4,472 | 1,610 | 144,953 | 149.4 K to 145 K (-2.99 %) |
Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 9,375 | 0 | 149,425 | 140.1 K to 149.4 K (+6.69 %) |
Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 0.36 | 1,633 | 588 | 87,726 | 89.4 K to 87.7 K (-1.83 %) |
Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 5,000 | 0 | 89,359 | 84.4 K to 89.4 K (+5.93 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 4,687 | 0 | 9,375 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 3,125 | 0 | 3,125 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 0.63 | 3,369 | 2,122 | 84,359 | 87.7 K to 84.4 K (-3.84 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 10,312 | 0 | 87,728 | 77.4 K to 87.7 K (+13.32 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | M | 0.00 | 3,125 | 0 | 6,250 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Payment of Exercise | F | 0.63 | 1,021 | 643 | 11,588 | 12.6 K to 11.6 K (-8.10 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Buy | M | 0.00 | 3,125 | 0 | 12,609 | 9.5 K to 12.6 K (+32.95 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 9,375 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 3,125 | 0 | 3,125 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 18,750 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 6,250 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 0 | |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 10,312 | 0 | 84,055 | 73.7 K to 84.1 K (+13.98 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Payment of Exercise | F | 0.63 | 9,690 | 6,105 | 140,050 | 149.7 K to 140.1 K (-6.47 %) |
Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 20,312 | 0 | 149,740 | 129.4 K to 149.7 K (+15.69 %) |
Aug 23 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
Aug 23 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Sell | S | 0.57 | 1,380 | 787 | 9,484 | 10.9 K to 9.5 K (-12.70 %) |